Ibuprofen Lysine Solution
Product Images NDC 66993-490

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ibuprofen Lysine (NDC 66993-490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3pk Ibuprofen Lysine

The packaging label for Ibuprofen Lysine Injection 10 mg/mL (20 mg/2 mL) sterile solution for intravenous use by Prasco Laboratories. The label indicates it is a prescription drug, supplied in 3 x 2 mL single dose vials. The label includes NDC 66993-490 and a barcode.*

FDA Label Image

Table 1 (Table 1)

A data table titled 'Adverse Events within 30 Days of Therapy in the Multicenter Study' comparing percentage incidence of various adverse events between ibuprofen lysine and placebo groups. Events include sepsis, anemia, bleeding, intraventricular hemorrhage, apnea, gastrointestinal disorders, renal events, respiratory infections, skin irritation, hypoglycemia, among others, with corresponding incidence rates for each group.*

FDA Label Image

Structural Formula (Structuralformula)

Chemical structure of ibuprofen lysine showing its molecular components including a benzene ring attached to a carboxylic acid group, a methyl group, and lysine side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.